CD40 ligation ablates the tolerogenic potential of lymphoid dendritic cells

Journal of Immunology

Volumn 166, Issue 1, 2001, Pages 277-283

  Grohmann, U ^a   Fallarino, F ^a   Silla, S ^a   Bianchi, R ^a   Belladonna, M L ^a   Vacca, C ^a   Micheletti, A ^a   Fioretti, M C ^a   Puccetti, P ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 12;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CELL SUBPOPULATION; CONTROLLED STUDY; DENDRITIC CELL; DIABETES MELLITUS; DIABETOGENESIS; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; LYMPHOID CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0035160559     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.1.277     Document Type: Article

References (44)

1. Heterogeneity of mouse spleen dendritic cells: In vivo phagocytic activity, expression of macrophage markers, and subpopulation turnover
2. The control of T cell responses by dendritic cell subsets
3. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis
4. The evolution of self-tolerance: A new cell arises to meet the challenge of self-reactivity
5. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells
6. - subclasses of dendritic cells direct the development of distinct T helper cells in vivo
7. + dendritic cells generate an immune response after subcutaneous injection without homing to the draining lymph node
8. Developmental pathways of dendritic cells in vivo: Distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice
9. + lymphoid dendritic cells
10. IL-12 is both required and sufficient for initiating T cell reactivity to a class I-restricted tumor peptide (P815AB) following transfer of P815AB-pulsed dendritic cells
11. A tumor-associated and self antigen peptide presented by dendritic cells may induce T cell anergy in vivo, but IL-12 can prevent or revert the anergic state
12. IL-12 acts directly on DC to promote nuclear localization of NF-κB and primes DC for IL-12 production
13. - dendritic cells to enhance presentation of a tumor peptide in vivo
14. + subset
15. Role of antigen-presenting cells in mediating tolerance and autoimmunity
16. Autocrine IL-12 is involved in dendritic cell modulation via CD40 ligation
17. + T cell response against one peptide/MHC complex in autoimmune diabetes
18. Progression of autoimmune diabetes driven by avidity maturation of a T-cell population
19. Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation
20. Th1 and Th2 cell clones to a poorly immunogenic tumor antigen initiate CD8+ T cell-dependent tumor eradication in vivo
21. CD40-CD40 ligand
22. Final maturation of dendritic cells is associated with impaired responsiveness to IFN-γ and to bacterial IL-12 inducers: Decreased ability of mature dendritic cells to produce IL-12 during the interaction with Th cells
23. Dendritic cells and the control of immunity
24. Transfer of dendritic cells (DC) ex vivo stimulated with interferon-γ, (IFN-γ) down-modulates autoimmune diabetes in non-obese diabetic (NOD) mice
25. IFN-γ is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: A possible role for nitric oxide
26. Failure to suppress the expansion of the activated CD4 T cell population in interferon γ-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis
27. Interferon γ eliminates responding CD4 T cells during mycobacterial infection by inducing apoptosis of activated CD4 T cells
28. Inhibition of T cell proliferation by macrophage tryptophan catabolism
29. Constitutive class I-restricted exogenous presentation of self antigens in vivo
30. + T cells
31. High levels of a major histocompatibility complex II-self peptide complex on dendritic cells from the T cell areas of lymph nodes
32. H2 development
33. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo
34. Cytokines that regulate autoimmune responses
35. Paralysis of dendritic cell IL-12 production by microbial products prevents infection-induced immunopathology
36. Interleukin-12 in infectious diseases
37. Regulation of autoimmunity by proinflammatory cytokines
38. L-tryptophan-kynurenine pathway metabolite 3-hydroxyanthranilic acid induces apoptosis in macrophage-derived cells under pathophysiological conditions
39. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cells stimulatory capacity: T-T help via APC activation
40. CD40-CD40 ligand interactions in vivo regulate migration of antigen-bearing dendritic cells from the skin to draining lymph nodes
41. + T-helper and a T-killer cell
42. CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy
43. + T-cell tolerance to T-cell priming through in vivo ligation of CD40
44. The roles of CD28 and CD40 ligand in T cell activation and tolerance